Levin Capital Strategies’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
Other funds holding PAVM
VFA
XF
Levin Capital Strategies's PAVM Position: Q4 2023 in Review
Levin Capital Strategies sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 333 shares — an estimated $44.1K sold.
Levin Capital Strategies first reported a position in PAVM in Q3 2016 and held it in 26 quarters. The position peaked at $436K in Q1 2022. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.
- Levin Capital Strategies reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
- Levin Capital Strategies sold 333 PAVmed shares in Q4 2023, an estimated $44.1K.
- Levin Capital Strategies first reported a position in PAVmed in Q3 2016 and held it in 26 quarters.
- Levin Capital Strategies's PAVmed position peaked at $436K in Q1 2022.
- 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.
Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.